European Commission study shows 5% leap in European industrial R&D spending

The 2006 EU Industrial R&D Investment Scoreboard shows that the top 1000 EU companies increased their R&D by an average of 5.3 % in 2005. This figure is in line with the results of a Commission survey released earlier this year. The top 1000 non-EU companies raised their R&D investment by 7.7%, showing a world-wide boost in R&D spending. The EU maintains a high profile, with 18 of the top 50 R&D spenders and 5 of the 10 word-wide companies with the fastest R&D growth. These figures emerge from the analysis of the top 1000 EU and 1000 non-EU companies investing in R&D. The full report, including detailed sector-by-sector analysis will be available later this year.

Janez Potočnik, European Commissioner for Science and Research said "This year's R&D scoreboard is very encouraging. If this trend continues, we could gradually close the R&D investment gap. I hope that at the Lahti summit later this month, European leaders will support the Commission's proposals to go further to boost innovation in Europe, and give even more impetus to these positive developments."

After a period of sluggish R&D growth, this year's scoreboard shows a strong increase in R&D investment worldwide. An average growth rate for EU companies of 5.3% contrasts with last year's growth rate for 0.7% and a contraction of 2% in 2004. The R&D investment growth of companies in the rest of the world in 2005 was 7.7%, one percent higher than the previous year.

The EU companies continue to perform well among the top R&D investors. Of the worldwide top 50, 18 are EU companies, the same number as last year, including 5 of the 10 fastest R&D growth companies worldwide. From the rest of the world, the top 50 includes 18 US companies, 10 Japanese (2 less than last year), 2 Swiss and 2 South Korean (the 2006 Scoreboard reports high R&D growth by South Korean companies). Most of top R&D investors are from automobile & parts sector (13 companies), pharmaceuticals (11 companies) and IT Hardware (9 companies). Daimler-Chrysler is once again the biggest R&D investor among EU companies.

This year, the Scoreboard includes a larger proportion of companies from sectors showing high R&D growth rates, especially in the EU group, where the presence of companies in R&D-intensive sectors such as software & computer services and pharmaceutical & biotechnology has increased.

The EU Industrial R&D Investment Scoreboard is published annually by the European Commission (DG RTD and DG JRC-IPTS) as part of its Industrial Research Investment Monitoring (IRIM) activity. The number of companies in the Scoreboard increased from 1400 last year to 2000 in the present edition. Together, the 1000 companies from the EU and the 1000 from outside invested €371 billion in R&D, estimated to represent more than half of world corporate R&D investment.

Details of all 2000 companies including R&D and financial data and in-depth analysis of the data are available from http://iri.jrc.es. An in-depth analysis of the data will be published before the end of the year.

© European Communities, 2006

Most Popular Now

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...